These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39068102)

  • 1. A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis.
    Oliveira Ramos F; Zinterl C; Fonseca JE
    Best Pract Res Clin Rheumatol; 2024 Sep; 38(3):101984. PubMed ID: 39068102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of transition from pediatric to adult rheumatology care in juvenile idiopathic arthritis.
    de Oliveira RJ; Kishimoto ST; de Souza DP; Fernandes PT; Marini R; Appenzeller S
    Expert Rev Clin Immunol; 2021 Feb; 17(2):155-161. PubMed ID: 33393405
    [No Abstract]   [Full Text] [Related]  

  • 3. New advances in juvenile idiopathic arthritis.
    Huang JL
    Chang Gung Med J; 2012; 35(1):1-14. PubMed ID: 22483423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life, continuity of care and patient satisfaction: long-term outcomes of former patients of the Tuebingen Transition Program (TTP) - a retrospective cohort study.
    Boeker LS; Kuemmerle-Deschner JB; Saur SJ; Klotsche J; Erbis G; Hansmann S
    Pediatr Rheumatol Online J; 2022 Dec; 20(1):121. PubMed ID: 36575486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.
    Yamazaki S; Shimbo A; Akutsu Y; Takase H; Morio T; Mori M
    Pediatr Rheumatol Online J; 2020 Mar; 18(1):26. PubMed ID: 32293465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].
    Niewerth M; Minden K; Klotsche J; Horneff G
    Z Rheumatol; 2014 Aug; 73(6):532-40. PubMed ID: 25096586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
    McMahan R; Balfe LM; Greene L
    J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
    Relas H; Kosola S
    Clin Rheumatol; 2019 Mar; 38(3):785-791. PubMed ID: 30374749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study.
    Arnstad ED; Rypdal V; Peltoniemi S; Herlin T; Berntson L; Fasth A; Nielsen S; Glerup M; Ekelund M; Zak M; Aalto K; Nordal E; Romundstad PR; Rygg M;
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):961-969. PubMed ID: 30055093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes.
    Oliveira Ramos F; Rodrigues AM; Melo AT; Aguiar F; Brites L; Azevedo S; Duarte AC; Gomes JAM; Furtado C; Mourão AF; Sequeira G; Cunha I; Figueira R; Santos MJ; Fonseca JE
    Arthritis Res Ther; 2023 Sep; 25(1):177. PubMed ID: 37735435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.
    Nalbanti P; Kanakoudi-Tsakalidou F; Trachana M; Pratsidou-Gertsi P; Farmaki E; Bamidis P; Papachristou F
    Rheumatol Int; 2018 Jul; 38(7):1241-1250. PubMed ID: 29845429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile idiopathic arthritis overview and involvement of the temporomandibular joint: prevalence, systemic therapy.
    Carrasco R
    Oral Maxillofac Surg Clin North Am; 2015 Feb; 27(1):1-10. PubMed ID: 25483440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach.
    Castillo-Vilella M; Giménez N; Tandaipan JL; Quintana S; Modesto C
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):130. PubMed ID: 34419078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early predictors of outcome in juvenile idiopathic arthritis.
    Ravelli A; Martini A
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S89-93. PubMed ID: 14969057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
    Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics in juvenile idiopathic arthritis: a narrative review.
    Vanoni F; Minoia F; Malattia C
    Eur J Pediatr; 2017 Sep; 176(9):1147-1153. PubMed ID: 28725955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatments for juvenile idiopathic arthritis.
    Quartier P
    Joint Bone Spine; 2010 Dec; 77(6):511-6. PubMed ID: 20961790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
    Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
    Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing interactive technologies to improve health outcomes in juvenile idiopathic arthritis.
    Coda A; Sculley D; Santos D; Girones X; Brosseau L; Smith DR; Burns J; Rome K; Munro J; Singh-Grewal D
    Pediatr Rheumatol Online J; 2017 May; 15(1):40. PubMed ID: 28511689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership.
    McErlane F; Foster HE; Armitt G; Bailey K; Cobb J; Davidson JE; Douglas S; Fell A; Friswell M; Pilkington C; Strike H; Smith N; Thomson W; Cleary G
    Rheumatology (Oxford); 2018 Jan; 57(1):140-151. PubMed ID: 29069424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.